Menu

Blog

Page 1695

Nov 16, 2023

Joby’s milestone: Quiet electric air taxi takes flight over Manhattan

Posted by in category: transportation

Joby Aviation achieves a historic milestone with the first manned eVTOL air taxi flight in New York City, showcasing its commitment to quiet, emissions-free urban air travel.


Joby Aviation.

The demonstration at the Downtown Heliport in Manhattan showcased Joby’s commitment to revolutionizing urban air travel.

Continue reading “Joby’s milestone: Quiet electric air taxi takes flight over Manhattan” »

Nov 16, 2023

Sam Altman: GPT-5 underway and will substantially differ from GPT-4

Posted by in categories: futurism, robotics/AI

OpenAI is seeking more funds from Microsoft to build future models both companies can profit from.


Justin Sullivan/Getty.

Since its blockbuster product, ChatGPT, which came out in November last year, OpenAI has released improved versions of GPT, the AI model that powered the conversational chatbot. Its most recent iteration, GPT Turbo, offers a faster and cost-effective way to use GPT-4.

Nov 16, 2023

AI Model Weighs Epigenetic Factors to Predict Cancer Outcomes

Posted by in categories: biotech/medical, genetics, robotics/AI

Findings lay the groundwork for developing targeted therapies aimed at regulating epigenetic factors in cancer therapy.

Nov 16, 2023

You can now use AI in Google to help with your holiday shopping. Here’s how

Posted by in category: robotics/AI

Google is using artificial intelligence to try to make holiday shopping easier.

Nov 16, 2023

Supersonic nuclear-powered plane would fly from London to New York in less time than a soccer game

Posted by in categories: nuclear energy, transportation

Now that’s cool but you will probably only see rich people flying in it for a while, if it comes to be.


The supersonic, nuclear-powered plane concept flies nearly twice the speed of Concorde and could get from London to New York in less time than a soccer game.

Nov 16, 2023

What If Money Expired?

Posted by in category: economics

More than a century ago, a wild-eyed, vegetarian, free love-promoting German entrepreneur and self-taught economist named Silvio Gesell proposed a radical reformation of the monetary system as we know it.


A long-forgotten German economist argued that society and the economy would be better off if money was a perishable good. Was he an anarchist crank or the prophet of a better world?

Nov 16, 2023

Scientists find new way to supercharge lasers by a million times

Posted by in categories: computing, particle physics, transportation

Scientists from the UK and South Korea have discovered a way to create laser pulses 1,000 times stronger than currently possible. Using computer simulations, they have discovered that a new way of compressing the light can drastically increase its intensity to such an extent that it can extract particles from a vacuum. This new technique could open up doors for important discoveries into the very nature of matter.

Uncover the nature of matter

Continue reading “Scientists find new way to supercharge lasers by a million times” »

Nov 16, 2023

Warren Buffett Is Expected To Rake In Over $6 Billion In Dividends In The Next Year

Posted by in category: finance

Warren Buffett, the venerated investor and CEO of Berkshire Hathaway, is set to amass over $6 billion in dividend income in the coming year, with a significant portion of this windfall emanating from just three stocks. This substantial income stream underscores the effectiveness of Buffett’s investment strategy, one that favors profitability and long-term value.

Buffett’s predilection for dividend-bearing stocks isn’t just a matter of preference; it’s a testament to his investment acumen. Among his top dividend earners, Bank of America Corp BAC stands out, with expected dividend earnings of approximately $991.5 million. A leading financial institution, BofA has thrived in the higher interest rate environment, seeing a substantial increase in its net-interest income.

Nov 16, 2023

Putin Wants Russia to Win the Artificial Intelligence Race. Here’s Why it Won’t

Posted by in categories: biotech/medical, business, military, robotics/AI

“Whoever leads in AI will rule the world,” President Vladimir Putin declared at an address commencing the 2017 Russian school year. Six years later, despite intense focus from senior leadership and heavy investment from the federal budget and state-owned enterprises, Russia remains a laggard in this field, hobbled by international isolation and structural challenges.

Military, political, and business leaders in Moscow have long understood the importance of controlling the information space to secure their grasp on power. After the scare of social media powered “color revolutions” on Russia’s doorstep, Moscow doubled down on these efforts. But facing both headwinds intrinsic to the nature of generative AI and deep, self-inflicted wounds from the war in Ukraine, the window for Russia to take a lead is closing quickly.

Russia’s leaders were caught flat-footed by the rise of social media. The supposed dangers of emerging technology were brought to the fore by Chisinau’s so-called “ Twitter revolution,” when protests organized in part on American social networks prevented Moldova’s ardently pro-Russian Party of Communists from winning the election in 2009.

Nov 16, 2023

U.K. Greenlights World’s First Crispr Gene Editing Therapy

Posted by in categories: bioengineering, biotech/medical, genetics

The one-time treatment helped relieve symptoms of disease and could free patients from the need for bone marrow transplants or regular blood transfusions, Beach said, adding that the drug hopefully offers a permanent fix for the condition.

The MHRA said it identified no significant safety concerns during the trials and will continue to closely monitor Casgevy’s safety after approval.

Vertex CEO and President Reshma Kewalramanit celebrated Casgevy’s approval as “a historic day in science and medicine” and Samarth Kulkarni, CEO and Chairman of Crispr Therapeutics, said it will hopefully mark “the first of many applications of this Nobel Prize winning technology to benefit eligible patients with serious diseases.” The two companies are hoping for similarly positive decisions from the MHRA’s counterparts in the Europe Union and the U.S., which are in the process of evaluating Casgevy, also known as exa-cel. The Food and Drug Administration is expected to make a decision in early December and has a deadline of December 8. The agency appears poised to follow the MHRA and approve the treatment, with its advisors confident of the drug’s efficacy and benefit but wary of theoretical unintended consequences of genetic modifications.